Caitlin A Orsini1, Nicholas W Simon2. 1. Department of Psychology, The University of Texas at Austin, Austin, Texas. 2. Department of Psychology, University of Memphis, Memphis, Tennessee.
Abstract
Deficits in decision making are at the heart of many psychiatric diseases, such as substance abuse disorders and attention deficit hyperactivity disorder. Consequently, rodent models of decision making are germane to understanding the neural mechanisms underlying adaptive choice behavior and how such mechanisms can become compromised in pathological conditions. A critical factor that must be integrated with reward value to ensure optimal decision making is the occurrence of consequences, which can differ based on probability (risk of punishment) and temporal contiguity (delayed punishment). This article will focus on two models of decision making that involve explicit punishment, both of which recapitulate different aspects of consequences during human decision making. We will discuss each behavioral protocol, the parameters to consider when designing an experiment, and finally how such animal models can be utilized in studies of psychiatric disease.
Deficits in decision making are at the heart of many psychiatric diseases, such as substance abuse disorders and attention deficit hyperactivity disorder. Consequently, rodent models of decision making are germane to understanding the neural mechanisms underlying adaptive choice behavior and how such mechanisms can become compromised in pathological conditions. A critical factor that must be integrated with reward value to ensure optimal decision making is the occurrence of consequences, which can differ based on probability (risk of punishment) and temporal contiguity (delayed punishment). This article will focus on two models of decision making that involve explicit punishment, both of which recapitulate different aspects of consequences during human decision making. We will discuss each behavioral protocol, the parameters to consider when designing an experiment, and finally how such animal models can be utilized in studies of psychiatric disease.
Authors: Marci R Mitchell; Virginia G Weiss; B Sofia Beas; Drake Morgan; Jennifer L Bizon; Barry Setlow Journal: Neuropsychopharmacology Date: 2013-10-22 Impact factor: 7.853
Authors: Caitlin A Orsini; Sara C Heshmati; Tyler S Garman; Shannon C Wall; Jennifer L Bizon; Barry Setlow Journal: Neuropharmacology Date: 2018-07-20 Impact factor: 5.250
Authors: Caitlin A Orsini; Shelby L Blaes; Richard J Dragone; Sara M Betzhold; Alyssa M Finner; Jennifer L Bizon; Barry Setlow Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2019-10-30 Impact factor: 5.067